Detalhe da pesquisa
1.
15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges.
Eur J Haematol
; 112(1): 122-136, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706583
2.
Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease.
Br J Haematol
; 196(2): 374-379, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476808
3.
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients.
Immunol Cell Biol
; 100(1): 61-73, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34582592
4.
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant.
Hemasphere
; 8(4): e63, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566804
5.
Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings.
Transplant Cell Ther
; 29(12): 777.e1-777.e8, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678607
6.
Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B-cell acute lymphoblastic leukemia using multicolor flow cytometry.
Cytometry B Clin Cytom
; 102(3): 199-208, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212133
7.
Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India.
Front Oncol
; 12: 779230, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35299754
8.
Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent.
Cytometry B Clin Cytom
; 102(6): 462-470, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346307
9.
Expression of CD304/neuropilin-1 in adult b-cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment.
Int J Lab Hematol
; 43(5): 990-999, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33432783
10.
Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.
Cytometry B Clin Cytom
; 100(4): 434-445, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32896101
11.
Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion.
Cytometry B Clin Cytom
; 100(4): 421-433, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812702
12.
A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-106 and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients.
Cytometry B Clin Cytom
; 98(1): 57-67, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31197916